Head Yuanshi Dian Therapy in Burning Mouth Syndrome

Key facts

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Principal Investigator

Weilian Sun

Second Affiliated Hospital, School of Medicine, Zhejiang University

Intervention

oryzanol + vitamin B2 (riboflavin) + vitamin E(drug)

Enrollment

290 enrolled

Eligibility

25-90 years · All sexes

Timeline

2020 – 2022

Study locations (3)

• Guiyang Hospital of Stomatology, Guiyang, Guizhou, China
• Zhejiang Provincal Hospital of TCM, Hangzhou, Zhejiang, China
• Department of Oral Medicine, the Second Affiliated Hospital, School of Medicine Zhejiang University, Hangzhou, Zhejiang, China

Collaborators

Zhejiang Provincial Hospital of TCM · Guiyang Hospital of Stomatology

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Burning mouth syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT07506018
  MucoLock™ for Treatment of Stomatitis
  Baptist Health South Florida
• RECRUITINGPHASE1, PHASE2NCT06726161
  Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
  RayzeBio, Inc.
• RECRUITINGEARLY PHASE1NCT07016555
  Burning Mouth Syndrome: Symptoms and Management
  University of Massachusetts, Amherst
• ACTIVE NOT RECRUITINGNANCT07381361
  Photobiomodulation Therapy vs. Alpha-Lipoic Acid in Burning Mouth Syndrome Treatment
  Lu Jiang
• RECRUITINGPHASE4NCT06040190
  Effect of Treatments on Pain and Quality of Life in Individual With Burning Mouth Syndrome
  Federal University of Minas Gerais
• RECRUITINGNCT05819697
  Reducing Patient Memory Recall in the Burning Mouth Patient Population
  University of Pennsylvania

See all trials for Burning mouth syndrome →